The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional) |
93.273 |
PA-18-619 |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional) |
93.279 |
PAS-18-625 |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) |
93.279 |
PAS-18-624 |
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional) |
93.273 |
PA-18-620 |
| Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional) |
93.242 |
PA-18-621 |
| Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed) |
93.853 |
PA-18-623 |
| Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) |
93.853 |
PA-18-622 |
| FY2018 AmeriCorps Indian Tribes Grants |
94.006 |
CNCS-02-02-18 |
| 2018 AmeriCorps State and National Grants - Targeted Priority |
94.006 |
CNCS-02-01-18 |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) |
93.121, 93.279, 93.307, 93.399 |
PAR-18-611 |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) |
93.121, 93.279, 93.307, 93.399 |
PAR-18-612 |
| Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional) |
93.847 |
PA-18-615 |
| Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed) |
93.121, 93.213, 93.279, 93.853, 93.859 |
RFA-GM-18-002 |
| Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) |
93.393 |
PAR-18-616 |
| OVW FY 2018 Grants to Reduce Sexual Assault, Domestic Violence, Dating Violence and Stalking on Campus Program-Updated |
16.525 |
OVW-2018-14263 |
| Programs to Support Correction Reform in Armenia |
19.703 |
INL18CA0011-EAARMENIA-CREFORM-020118 |
| Rehabilitation Engineering Research Centers (RERC) Program: RERC on Physical Access and Transportation |
93.433 |
HHS-2018-ACL-NIDILRR-REGE-0259 |
| National Centers for Translational Research in Reproduction and Infertility [NCTRI] (P50 - Clinical Trial Optional) |
93.865 |
RFA-HD-19-017 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) |
93.395 |
PAR-18-606 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) |
93.395 |
PAR-18-605 |
| 2019 National Urban and Community Forestry Grant Program |
10.675 |
USDA-FS-UCF-01-2019 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) |
93.273, 93.279 |
PA-18-602 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional) |
93.273, 93.279 |
PA-18-601 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
93.853, 93.866 |
PAR-18-596 |
| Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
93.846 |
PAR-18-597 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) |
93.273, 93.279 |
PA-18-603 |
| Specially Adapted Housing Assistive Technology Grant Program |
64.051 |
VA-SAHAT-18-03 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
93.846 |
PAR-18-594 |
| Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) |
93.077, 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.281, 93.282, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.352, 93.361, 93.389, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.701, 93 |
PA-18-590 |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
93.077, 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.281, 93.282, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.352, 93.361, 93.389, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.701, 93 |
PA-18-589 |
| Service Area Competition-Additional Areas (SAC-AA) - Newark, NJ |
93.224 |
HRSA-18-108 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) |
93.846 |
PAR-18-595 |
| The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed) |
93.310 |
RFA-RM-18-001 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) |
93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.321, 93.350, 93.351, 93.352, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93 |
PA-18-591 |
| Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-015 |
| Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-017 |
| Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed) |
93.866 |
RFA-AG-19-001 |
| Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-013 |
| Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-016 |
| Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-018 |
Search Results 6601-6640 of 17636
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
